Allergan Plc has signed an agreement to acquire Elastagen Pty Ltd for $95m.

Based in Ireland, Allergan is a biopharmaceutical company, while Elastagen is an Australian company.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The acquisition will provide Allergan with access to Elastagen’s injectable portfolio.

The transaction is expected to be completed upon meeting customary closing conditions and following a review by Australia’s Foreign Investment Review Board.

Pacific Equity Partners PTY Limited (PEP) has signed an agreement to acquire 100% of LifeHealthcare Group’s shares for A$3.75 ($2.97).

The cash consideration represents an enterprise value of A$211m ($167m) for LifeHealthcare.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The selling shareholders of LifeHealthcare will receive A$3.75 ($2.97) a share in cash, as part of the agreement.

The transaction is subject to customary conditions, including foreign investment review board approval and court approval.

“The acquisition will enable the company to expand its manufacturing capabilities and address customer needs.”

Pacific Equity Partners is an Australian private equity firm, while LifeHealthcare Group, also based in Australia, is a medical device and healthcare solutions provider.

UBS AG, Australia has been appointed as the financial adviser by LifeHealthcare for the transaction, while Gilbert and Tobin is the legal adviser.

UFP Technologies Inc has acquired US-based Dielectrics Inc.

Also based in the US, UFP Technologies is a plastics and specialty materials designer.

The acquisition will enable the company to expand its manufacturing capabilities and address customer needs.

US-based medical device and software company Varian Medical Systems Inc has acquired Medical Systems LP.

Also located in the US, the target company is involved in providing radiation oncology Quality Assurance (QA) software.

The acquisition will enable Varian Medical to develop its QA portfolio by using Mobius QA solutions.